help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0826
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funder, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funder, J. W.
Endocrinology Vol. 147, No. 12 5564-5567
Copyright © 2006 by The Endocrine Society

Aldosterone and the Cardiovascular System: Genomic and Nongenomic Effects

John W. Funder

Prince Henry’s Institute of Medical Research, Clayton, Victoria, Australia 3168

Address all correspondence and requests for reprints to: John W. Funder, Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton 3168, Victoria, Australia. E-mail: john.funder{at}princehenrys.org.

There is clear evidence for rapid nongenomic effects of aldosterone in the cardiovascular system in addition to its well characterized effects of unidirectional transepithelial sodium transport. Many of these effects are mediated by the classical mineralocorticoid receptors, although others may be exerted independently. Given that mineralocorticoid receptors are largely constitutively occupied but not activated by physiological glucocorticoids, effects of aldosterone administered in vitro or in vivo may or may not equate with true physiological mineralocorticoid roles. In many systems (e.g. blood pressure regulation and cardiac fibrosis), the time course of effects is such that it is not possible, and perhaps not important, to distinguish between rapid nongenomic and classical genomic effects in the context of homeostatic physiology.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. J. Becker, T. D. Hewitson, and A. Chrysostomou
Aldosterone in clinical nephrology--old hormone, new questions
Nephrol. Dial. Transplant., June 3, 2009; (2009) gfp256v1.
[Full Text] [PDF]


Home page
EndocrinologyHome page
N. Lopez-Andres, C. Inigo, I. Gallego, J. Diez, and M. A. Fortuno
Aldosterone Induces Cardiotrophin-1 Expression in HL-1 Adult Cardiomyocytes
Endocrinology, October 1, 2008; 149(10): 4970 - 4978.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. G. Romero, M. W. Plonczynski, B. L. Welsh, C. E. Gomez-Sanchez, M. Y. Zhou, and E. P. Gomez-Sanchez
Gene expression profile in rat adrenal zona glomerulosa cells stimulated with aldosterone secretagogues
Physiol Genomics, December 19, 2007; 32(1): 117 - 127.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev., December 1, 2007; 28(7): 726 - 741.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Rickard, J. W. Funder, J. Morgan, P. J. Fuller, and M. J. Young
Does Glucocorticoid Receptor Blockade Exacerbate Tissue Damage after Mineralocorticoid/Salt Administration?
Endocrinology, October 1, 2007; 148(10): 4829 - 4835.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society